More and more people are talking about Novartis over the last few weeks. Is it worth buying the Pharmaceutical stock at a price of $112.13? Only time will tell. The information below will give you a ...

Since 2016, the FDA has approved three disease-modifying treatments for spinal muscular atrophy, with several ...

Biosimilars are essential healthcare equalizers, but their regulation is overly complicated due to lobbying by makers of ...

SINGAPORE – A new programme has launched in Singapore to formally study the applications of ribonucleic acid (RNA) in vaccine ...

The Global Recombinant Chemicals Market is valued at approximately USD 2.9 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 7.8% over the forecast period 2024-2032.

The global neurodegenerative disease market is on a trajectory of significant expansion, with its valuation expected to surge from USD 52.08 billion in 2024 to USD 102.4 billion by 2034, reflecting a ...